Coverage continues for type 2 diabetes, cardiovascular disease, obstructive sleep apnea, and MASH liver disease with prior authorization
The blend cannot be split into its components after reconstitution, so a protocol requiring the two at an independently chosen ratio needs separate vials rather than this format
RETRACTED: neuroprotective and neurotrophic effects of apigenin and luteolin in MPTP induced Parkinsonism in mice
Neuropsychopharmacology 40 , 755765 (2015)
These sweeteners may come from plant sources, undergo less processing, or have a lower glycemic index (GI), making them more suitable for people with dietary restrictions, including diabetics, GLP-1 users, and those following ketogenic or paleo diets